Cathal Friel of Open Orphan and Philip Haydn-Slater of Riverfort Global Opportunities
Episode 1638, Nov 18, 2019, 12:27 PM
Open Orphan talk about the signing of a contract with Carna Bioscience. Riverfort Global Opportunities describe their progress in the third quarter of this year.
On the Vox Markets Podcast Today: 18th November 2019
Cathal Friel, Chief Executive Officer of Open Orphan #ORPH talks about the signing of a contract with Carna Bioscience which is expected to deliver significant revenue for the Company.
Philip Haydn-Slater, Non-Executive Chairman of Riverfort Global Opportunities #RGO describes their progress in the third quarter of this year.
(Interview starts at 10 minutes 6 seconds)
Plus the Top 5 Most Followed Companies & the Top 5 Most Liked RNS’s on Vox Markets in the last 24 hours.
Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.
#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Investments #Finance #Business #Podcast